Cancer survival in colon and lung cancer: how new therapies and access to care affect outcomes
Official title: A Systems Theory Approach to the Study of Colon and Lung Cancer Survivorship Using Novel Data Linkages
Funded at University of South Carolina at Columbia · NIH-11416540 · Data updated 2026-11-12
This grant links state cancer data, insurance claims, and mental health records to study how younger cancer patients use new targeted therapies and what factors influence their survival.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Carolina at Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | September 16, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $1,017,131 |
| NIH project number | 4R01CA287360-03 |
| Project ID | NIH-11416540 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants are individuals with lung or colon cancer under 65 whose care data can be linked across registries, claims, and mental health records.
✕Less likely to help
Patients whose data cannot be linked or who are older than 65 may have limited direct benefit.
What this research studies
This project will create a population-based cohort of cancer patients under 65 by linking state cancer registry data with all-payer claims and mental health treatment sources. It will look at how access to care and the use of novel targeted therapies relate to survival trajectories, while considering treatment, co-morbidities, and social factors. The study will analyze patterns across multiple domains to understand what helps patients live longer after a colon or lung cancer diagnosis. Results could guide efforts to improve treatment uptake and survivorship support for younger patients.
Why it matters
Potential benefit: If successful, the findings could inform policies and practices that improve access to targeted therapies and support services for younger cancer survivors.
How similar studies have gone: Past work has shown that data linkages can reveal gaps in treatment access and survival patterns, but this project targets younger patients and emerging therapies.
Where this research is happening
-
University of South Carolina at Columbia
Columbia, United States Active
Researchers
- Principal investigator: Adams, Swann Arp — University of South Carolina at Columbia
- Study coordinator: Adams, Swann Arp
Related research
Other NIH-funded projects on the same topics.
-
Understanding colon and lung cancer survivorship through linked health records
This project links cancer registry, insurance claims, and mental health records to learn how treatments, other health conditions, and access to care affect survival for people with colon and lung cancer, including adults under 65.
-
Personalized survivorship support for rural lung cancer survivors
This program offers personalized survivorship support for rural lung cancer survivors to improve quality of life, reduce stigma, and help people stay connected to care.
-
Improving care for lung cancer survivors in rural communities
This study is all about helping lung cancer survivors in rural Kentucky live better lives by offering personalized care and support, and it’s designed for those who have battled lung cancer and want to be more involved in their recovery journey.
-
Optimizing lung cancer care with smart tools for prevention, early detection, treatment, and survivorship
A U01 grant using AI and biomarkers to improve lung cancer prevention, screening, treatment, and survivorship care for people at risk or living with lung cancer.
-
OPC Survivor: Optimizing Long-Term Health After Oropharyngeal Cancer
This program studies how to improve long-term health and quality of life for adults treated for HPV-related oropharyngeal cancer.
-
Predicting Late Effects in Childhood Cancer Survivors Using Patient-Generated Health Data
This grant tests a mobile health approach to track symptoms, activity, sleep, and heart rate in adults who survived childhood cancer to predict future health problems and guide care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.